Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02711553 |
|---|---|
| Brief Title: | A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract Cancer |
| First Submitted : | March 14, 2016 |
| First Submitted that Met QC Criteria : | March 14, 2016 |
| First Posted : | March 17, 2016 (Estimate) |
| Results First Submitted : | February 8, 2021 |
| Results First Submitted that Met QC Criteria : | February 8, 2021 |
| Results First Posted : | February 26, 2021 |
| Certification/Extension First Submitted : | February 8, 2019 |
| Certification/Extension First Submitted that Met QC Criteria : | February 8, 2019 |
| Certification/Extension First Posted : | February 12, 2019 |
| Last Update Submitted that Met QC Criteria : | October 18, 2022 |
| Last Update Posted : | October 20, 2022 |